Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis

Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significa...

Full description

Saved in:
Bibliographic Details
Published inProgress in neuro-psychopharmacology & biological psychiatry Vol. 80; no. Pt C; pp. 217 - 226
Main Authors Więdłocha, Magdalena, Marcinowicz, Piotr, Krupa, Renata, Janoska-Jaździk, Marlena, Janus, Marta, Dębowska, Weronika, Mosiołek, Anna, Waszkiewicz, Napoleon, Szulc, Agata
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 03.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines. We performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment. Statistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP. Antidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies.
AbstractList Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines. We performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment. Statistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP. Antidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies.
Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines.INTRODUCTIONMajor Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines.We performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment.METHODSWe performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment.Statistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP.RESULTSStatistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP.Antidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies.CONCLUSIONSAntidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies.
Author Marcinowicz, Piotr
Mosiołek, Anna
Janus, Marta
Szulc, Agata
Waszkiewicz, Napoleon
Dębowska, Weronika
Krupa, Renata
Więdłocha, Magdalena
Janoska-Jaździk, Marlena
Author_xml – sequence: 1
  givenname: Magdalena
  orcidid: 0000-0001-8353-7820
  surname: Więdłocha
  fullname: Więdłocha, Magdalena
  email: mwiedlocha@wp.pl
  organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland
– sequence: 2
  givenname: Piotr
  surname: Marcinowicz
  fullname: Marcinowicz, Piotr
  organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland
– sequence: 3
  givenname: Renata
  surname: Krupa
  fullname: Krupa, Renata
  organization: Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Poland
– sequence: 4
  givenname: Marlena
  surname: Janoska-Jaździk
  fullname: Janoska-Jaździk, Marlena
  organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland
– sequence: 5
  givenname: Marta
  surname: Janus
  fullname: Janus, Marta
  organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland
– sequence: 6
  givenname: Weronika
  surname: Dębowska
  fullname: Dębowska, Weronika
  organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland
– sequence: 7
  givenname: Anna
  surname: Mosiołek
  fullname: Mosiołek, Anna
  organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland
– sequence: 8
  givenname: Napoleon
  surname: Waszkiewicz
  fullname: Waszkiewicz, Napoleon
  organization: Department of Psychiatry, Faculty of Medicine, Medical University in Bialystok, Poland
– sequence: 9
  givenname: Agata
  surname: Szulc
  fullname: Szulc, Agata
  organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28445690$$D View this record in MEDLINE/PubMed
BookMark eNp9kb9u1TAUhy1URG8LT4CEMrIkHDu24wwMVVX-SJVYYGCyHPtY-JI4wfZF6tZ34A15EtzedmHo5J-Oft-RzuczchLXiIS8ptBRoPLdvtviNm0dAzp0wDtg8hnZUTWoljMqT8gOWM1CcXlKznLeAwDtoX9BTpniXMgRduT7lfdoS7P6xsQSHG4Jc66xKQlNWbCmNTYbprD9wGTmJkQ_m2UxJdT5YtJPTLn5e_unuWgWLKY10cw3OeSX5Lk3c8ZXD-85-fbh6uvlp_b6y8fPlxfXreVMlBbH3iqUvfReOcY4DIZbAwwdInMDuDpSXkpnQFgq7KQmwSfwzMtJjNj35-Ttce-W1l8HzEUvIVucZxNxPWRN1cgGJsTIa_XNQ_UwLej0lkI94EY_6qiF8Viwac05odc2lPtLSzJh1hT0nXq91_fq9Z16DVxX9ZXt_2Mf1z9NvT9SWBX9Dph0tgGjRRdS_Rft1vAk_w_OcqBn
CitedBy_id crossref_primary_10_1186_s13550_018_0401_9
crossref_primary_10_1016_j_jad_2024_09_172
crossref_primary_10_1016_j_bbih_2021_100232
crossref_primary_10_1016_j_jad_2022_06_080
crossref_primary_10_1016_j_jad_2021_08_126
crossref_primary_10_1016_j_jad_2023_02_064
crossref_primary_10_34067_KID_0000062020
crossref_primary_10_1016_j_brainres_2019_146398
crossref_primary_10_1016_j_euroneuro_2021_11_003
crossref_primary_10_1159_000513093
crossref_primary_10_37376_benunivmedj_v1i1_7141
crossref_primary_10_1097_j_pain_0000000000001997
crossref_primary_10_1007_s10067_022_06455_x
crossref_primary_10_1089_jwh_2017_6878
crossref_primary_10_1523_JNEUROSCI_1004_18_2018
crossref_primary_10_1177_0003319718780145
crossref_primary_10_1016_j_jbspin_2021_105200
crossref_primary_10_2147_JIR_S387588
crossref_primary_10_1186_s12889_025_22303_4
crossref_primary_10_1016_j_ypmed_2020_106050
crossref_primary_10_1097_MD_0000000000014419
crossref_primary_10_1186_s40345_019_0152_1
crossref_primary_10_1016_j_jad_2019_02_042
crossref_primary_10_1016_j_biopha_2020_111200
crossref_primary_10_1002_rmv_2417
crossref_primary_10_1016_j_neubiorev_2018_03_023
crossref_primary_10_3389_fpsyt_2021_801738
crossref_primary_10_1016_j_intimp_2023_110108
crossref_primary_10_1016_j_jpsychires_2025_01_036
crossref_primary_10_2174_1570159X20666220627160048
crossref_primary_10_1016_j_bbih_2022_100579
crossref_primary_10_1016_j_neubiorev_2023_105425
crossref_primary_10_3390_ijms24076664
crossref_primary_10_1016_j_bbi_2020_04_013
crossref_primary_10_5114_reum_154905
crossref_primary_10_1007_s00406_021_01245_z
crossref_primary_10_1159_000506133
crossref_primary_10_37939_jrmc_v27i4_2343
crossref_primary_10_3390_app142411540
crossref_primary_10_1017_neu_2021_44
crossref_primary_10_22159_ijpps_2022v14i3_43662
crossref_primary_10_1080_15622975_2021_2013095
crossref_primary_10_3389_fgene_2022_865015
crossref_primary_10_1111_cen3_12537
crossref_primary_10_4103_indianjpsychiatry_indianjpsychiatry_380_22
crossref_primary_10_1016_j_brainres_2023_148723
crossref_primary_10_1016_j_bbih_2024_100925
crossref_primary_10_1177_2632010X231180797
crossref_primary_10_1111_bcpt_13385
crossref_primary_10_1007_s00393_018_0568_5
crossref_primary_10_1016_j_pnpbp_2019_01_001
crossref_primary_10_1177_17590914231181037
crossref_primary_10_1177_0269881120936486
crossref_primary_10_3389_fgene_2018_00561
crossref_primary_10_1159_000505275
crossref_primary_10_3390_brainsci14090850
crossref_primary_10_1038_s41398_020_00933_z
crossref_primary_10_1186_s12974_022_02429_7
crossref_primary_10_1136_bmjopen_2020_048162
crossref_primary_10_3389_fimmu_2019_01696
crossref_primary_10_3390_biomedicines10081929
crossref_primary_10_1016_j_jpsychires_2019_03_027
crossref_primary_10_3390_ijms20112778
crossref_primary_10_1523_JNEUROSCI_2673_17_2018
crossref_primary_10_1016_j_jpsychires_2021_01_018
crossref_primary_10_1016_j_bbr_2020_113003
crossref_primary_10_1186_s40779_024_00577_w
crossref_primary_10_1016_j_psyneuen_2022_105770
crossref_primary_10_1177_20451253211034320
crossref_primary_10_3390_molecules25143207
crossref_primary_10_1080_08964289_2019_1604489
crossref_primary_10_1016_j_bbi_2023_03_025
crossref_primary_10_1016_j_phrs_2024_107322
crossref_primary_10_3389_fpsyt_2023_1163754
crossref_primary_10_1016_j_jad_2022_09_092
crossref_primary_10_1186_s12974_025_03403_9
crossref_primary_10_3390_molecules27113551
crossref_primary_10_1038_s41398_020_00920_4
crossref_primary_10_1016_j_bbi_2020_01_011
crossref_primary_10_1038_s41398_019_0424_7
crossref_primary_10_1080_14737175_2018_1407242
crossref_primary_10_1016_j_joen_2019_07_017
crossref_primary_10_1016_S2215_0366_20_30564_2
crossref_primary_10_2174_1381612826666200406090051
crossref_primary_10_3389_fpsyt_2024_1366942
crossref_primary_10_5114_reum_2022_114352
crossref_primary_10_1016_j_jad_2022_04_038
crossref_primary_10_3389_fnins_2018_00499
crossref_primary_10_1016_j_jad_2020_07_125
crossref_primary_10_3389_fpsyt_2020_00522
crossref_primary_10_3390_endocrines5040035
crossref_primary_10_1016_j_jpsychires_2022_12_032
crossref_primary_10_1038_s41598_020_57967_y
crossref_primary_10_1016_j_bbih_2023_100685
crossref_primary_10_3390_genes11091089
crossref_primary_10_1016_j_pnpbp_2021_110343
crossref_primary_10_2139_ssrn_4069176
crossref_primary_10_1371_journal_pone_0269033
crossref_primary_10_1016_j_rhum_2022_04_002
crossref_primary_10_4103_jmedsci_jmedsci_124_23
crossref_primary_10_1016_j_brainresbull_2022_10_021
crossref_primary_10_1093_brain_awaa405
crossref_primary_10_1016_j_jad_2020_01_048
crossref_primary_10_3390_ijms24054772
crossref_primary_10_1016_j_jpsychires_2022_03_004
crossref_primary_10_1016_j_euroneuro_2020_10_005
crossref_primary_10_1016_j_jad_2021_09_022
crossref_primary_10_1016_j_encep_2021_08_002
crossref_primary_10_1038_s41398_019_0521_7
crossref_primary_10_1016_j_jpsychires_2018_12_007
crossref_primary_10_1038_s41584_023_01037_w
crossref_primary_10_3390_jcm10081706
crossref_primary_10_1016_j_jad_2018_04_115
crossref_primary_10_1080_14656566_2018_1528230
crossref_primary_10_3389_fnbeh_2023_1282242
crossref_primary_10_1186_s12888_024_05910_0
crossref_primary_10_1016_j_euroneuro_2021_09_006
crossref_primary_10_3389_fphar_2022_874375
crossref_primary_10_1016_j_psychres_2022_114725
crossref_primary_10_33808_clinexphealthsci_824534
crossref_primary_10_3390_ijerph19159573
crossref_primary_10_3390_ijms19010233
crossref_primary_10_1016_j_npbr_2019_07_007
crossref_primary_10_1080_15622975_2021_1961502
crossref_primary_10_1186_s12974_021_02245_5
crossref_primary_10_1017_S1092852919001469
crossref_primary_10_3389_fimmu_2020_00388
crossref_primary_10_1016_j_ejphar_2025_177525
crossref_primary_10_2174_1570159X20666220411101217
crossref_primary_10_1016_j_psyneuen_2021_105200
crossref_primary_10_1038_s41598_024_61865_y
crossref_primary_10_1111_eip_12775
crossref_primary_10_1007_s12035_021_02718_x
crossref_primary_10_1055_a_1531_4460
crossref_primary_10_3389_fpsyt_2020_00704
crossref_primary_10_1080_14737159_2018_1470927
crossref_primary_10_3389_fimmu_2023_1183115
crossref_primary_10_1016_j_psyneuen_2024_107145
crossref_primary_10_1016_j_lanepe_2024_101166
crossref_primary_10_1038_s41598_024_61523_3
crossref_primary_10_1001_jamapsychiatry_2020_1214
crossref_primary_10_1016_j_bpsgos_2024_100332
crossref_primary_10_1016_j_jagp_2018_07_005
crossref_primary_10_1016_j_canlet_2022_215648
crossref_primary_10_1016_j_phrs_2022_106145
crossref_primary_10_1177_1759720X221111613
crossref_primary_10_3390_jcm11216352
crossref_primary_10_1016_j_brainresbull_2024_111131
crossref_primary_10_3390_ijms23031616
crossref_primary_10_1016_j_pnpbp_2025_111251
crossref_primary_10_3390_jpm11020114
crossref_primary_10_1016_j_bbi_2018_10_012
crossref_primary_10_1016_j_chc_2022_08_012
crossref_primary_10_1016_j_jad_2019_04_088
crossref_primary_10_1053_j_ajkd_2019_09_007
crossref_primary_10_3390_medicines9030022
crossref_primary_10_1038_s41380_022_01819_w
crossref_primary_10_1016_j_revmed_2018_07_014
crossref_primary_10_3390_cells8010052
crossref_primary_10_1016_j_bbi_2019_12_017
crossref_primary_10_1016_j_neuron_2020_06_002
crossref_primary_10_1097_BOR_0000000000000597
crossref_primary_10_1016_j_jpsychires_2022_12_009
crossref_primary_10_1016_j_jad_2021_03_036
crossref_primary_10_1007_s11011_019_00432_1
crossref_primary_10_1016_j_bbi_2024_08_054
crossref_primary_10_7759_cureus_62991
crossref_primary_10_1007_s12640_017_9859_x
crossref_primary_10_1016_j_jpsychires_2019_10_012
crossref_primary_10_1038_s41398_020_01035_6
crossref_primary_10_1016_j_neuroscience_2020_05_014
Cites_doi 10.1016/j.psyneuen.2012.05.005
10.1017/S1092852900013754
10.1016/j.jad.2012.08.007
10.1016/j.euroneuro.2015.06.007
10.1179/1476830513Y.0000000066
10.1016/j.biopsych.2009.09.033
10.1159/000444220
10.1111/j.1440-1681.2008.05077.x
10.3390/ijms16047796
10.1111/acps.12576
10.1038/npp.2011.132
10.1016/j.pnpbp.2013.09.016
10.1016/S0306-9877(03)00207-X
10.1007/s00213-003-1566-z
10.1016/j.jad.2013.06.004
10.2147/NDT.S16382
10.1016/S0893-133X(99)00134-7
10.1001/jamapsychiatry.2014.1611
10.1007/BF02900219
10.1007/s00213-015-4044-5
10.1016/0197-2456(86)90046-2
10.1007/s00702-011-0668-8
10.1016/j.jpsychires.2016.01.008
10.1016/j.neuint.2007.06.037
10.1016/j.jad.2012.03.033
10.1016/S0893-133X(00)00089-0
10.2174/157015912800604542
10.3109/15622970802573246
10.1016/j.psychres.2016.02.052
10.1016/j.jad.2006.07.013
10.1038/sj.mp.4001032
10.1007/s00213-013-3322-3
10.1097/PSY.0b013e3181f883ce
10.1016/j.euroneuro.2008.08.001
10.1055/s-2002-36390
10.1016/j.psychres.2009.04.013
10.1192/bjp.bp.105.011015
10.1006/cyto.1997.0238
10.1002/hup.2333
10.1007/s004060170058
10.1155/2013/267871
10.1002/art.27304
10.1016/0165-0327(95)00028-L
10.1016/j.jpsychires.2015.04.026
10.1038/npp.2011.277
10.1155/2010/573594
10.1002/hup.717
10.1155/2007/76396
10.1017/S0033291712000128
10.1016/j.pnpbp.2007.09.015
10.1016/j.bbi.2011.07.239
10.1038/mp.2010.52
10.1136/bmj.327.7414.557
10.1002/hup.2525
10.1016/S0924-977X(01)00081-5
10.1016/j.pbb.2012.12.003
10.1111/j.1749-6632.1995.tb32372.x
ContentType Journal Article
Copyright 2017 Elsevier Inc.
Copyright © 2017 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2017 Elsevier Inc.
– notice: Copyright © 2017 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.pnpbp.2017.04.026
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1878-4216
EndPage 226
ExternalDocumentID 28445690
10_1016_j_pnpbp_2017_04_026
S0278584617300659
Genre Meta-Analysis
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
123
1B1
1RT
1~.
1~5
4.4
457
4G.
5RE
7-5
71M
8P~
9JM
AABNK
AACTN
AADPK
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AATCM
AAXLA
AAXUO
ABCQJ
ABFRF
ABIVO
ABJNI
ABMAC
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
L7B
M2V
M34
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SES
SSN
SSP
SSZ
T5K
TEORI
~G-
.GJ
29P
53G
5VS
AAQFI
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ABXDB
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AHHHB
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CITATION
FEDTE
FGOYB
G-2
HMQ
HMT
HVGLF
HZ~
R2-
SEW
SNS
SPT
SSH
WUQ
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
ID FETCH-LOGICAL-c425t-e93c8e636ff8d22407a4ca02edee2d70d2408f66da05c15cb8b54b0f2f6b59e33
IEDL.DBID .~1
ISSN 0278-5846
1878-4216
IngestDate Tue Aug 05 11:27:48 EDT 2025
Wed Feb 19 02:41:44 EST 2025
Tue Jul 01 01:50:20 EDT 2025
Thu Apr 24 23:07:14 EDT 2025
Fri Feb 23 02:30:46 EST 2024
IsPeerReviewed true
IsScholarly true
Issue Pt C
Keywords Depression
Inflammation
Cytokines
Antidepressants
Meta-analysis
Language English
License Copyright © 2017 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c425t-e93c8e636ff8d22407a4ca02edee2d70d2408f66da05c15cb8b54b0f2f6b59e33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8353-7820
PMID 28445690
PQID 1892725594
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1892725594
pubmed_primary_28445690
crossref_citationtrail_10_1016_j_pnpbp_2017_04_026
crossref_primary_10_1016_j_pnpbp_2017_04_026
elsevier_sciencedirect_doi_10_1016_j_pnpbp_2017_04_026
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-03
PublicationDateYYYYMMDD 2018-01-03
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-03
  day: 03
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Progress in neuro-psychopharmacology & biological psychiatry
PublicationTitleAlternate Prog Neuropsychopharmacol Biol Psychiatry
PublicationYear 2018
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Köhler, Benros, Nordentoft, Farkouh, Iyengar, Mors, Krogh (bb0160) 2014; 71
Myint, Kim (bb0210) 2003; 61
Sutcigil, Oktenli, Musabak, Bozkurt, Cansever, Uzun, Sanisoglu, Yesilova, Ozmenler, Ozsahin, Sengul (bb0280) 2007; 2007
Ninan, Shelton, Bao, Guico-Pabia (bb0220) 2014; 48
Brunoni, Machado-Vieira, Zarate, Valiengo, Vieira, Benseñor, Lotufo, Gattaz, Teixeira (bb0025) 2014; 231
Crnković, Buljan, Karlović, Krmek (bb0040) 2012; 51
Myint, Kim, Verkerk, Scharpé, Steinbusch, Leonard (bb0215) 2007; 98
Yoshimura, Hori, Ikenouchi-Sugita, Umene-Nakano, Katsuki, Atake, Nakamura (bb0300) 2013; 28
Dahl, Ormstad, Aass, Sandvik, Malt, Andreassen (bb0045) 2016; 134
Maes, Bosmans, De Jongh, Kenis, Vandoolaeghe, Neels (bb0190) 1997; 9
Chang, Lee, Gean, Lee, Chi, Yang, Lu, Chen (bb0030) 2012; 26
Basterzi, Aydemir, Kisa, Aksaray, Tuzer, Yazici, Göka (bb0010) 2005; 20
Abbasi, Hosseini, Modabbernia, Ashrafi, Akhondzadeh (bb0005) 2012; 141
Lanquillon, Krieg, Bening-Abu-Shach, Vedder (bb0170) 2000; 22
Manoharan, Rajkumar, Shewade, Sundaram, Muthuramalingam, Paul (bb0195) 2016; 31
Strawbridge, Arnone, Danese, Papadopoulos, Herane Vives, Cleare (bb0275) 2015; 25
Hannestad, DellaGioia, Bloch (bb0115) 2011; 36
Hernández, Mendieta, Martínez-Fong, Loría, Moreno, Estrada, Bojalil, Pavón, Hernández, Mendieta, Martínez-Fong, Loría, Moreno, Estrada, Bojalil, Pavón (bb0125) 2008; 18
Eller, Vasar, Shlik, Maron (bb0075) 2008; 32
Shelton, Claiborne, Sidoryk-Wegrzynowicz, Reddy, Aschner, Lewis, Mirnics (bb0265) 2011; 2011
Baumeister, Ciufolini, Mondelli (bb0015) 2016; 233
Hinze-Selch, Schuld, Kraus, Kühn, Uhr, Haack, Pollmächer (bb0145) 2000; 23
World Health Organization (bb0295) 2008
Del Grande da Silva, Wiener, Barbosa, Gonçalves Araujo, Molina, San Martin, Oses, Jansen, Dias de Mattos Souza, Azevedo da Silva (bb0050) 2016; 75
Drevets, Savitz, Trimble (bb0065) 2008; 13
Fornaro, Rocchi, Escelsior, Contini, Martino (bb0090) 2013; 145
Higgins, Thompson, Deeks, Altman (bb0135) 2003; 327
Mikova, Yakimova, Bosmans, Kenis, Maes (bb0205) 2001; 11
Piletz, Halaris, Iqbal, Hoppensteadt, Fareed, Zhu, Sinacore, Devane (bb0240) 2009; 10
Tuglu, Kara, Caliyurt, Vardar, Abay (bb0285) 2003; 170
Fornaro, Martino, Battaglia, Colicchio, Perugi (bb0085) 2011; 7
Chen, Lin, Chen, Mao, Hung (bb0035) 2010; 2010
O'Brien, Scott, Dinan (bb0225) 2006; 188
Sacre, Medghalchi, Gregory, Brennan, Williams (bb0255) 2010; 62
Frommberger, Bauer, Haselbauer, Fräulin, Riemann, Berger (bb0095) 1997; 247
Hiles, Baker, de Malmanche, Attia (bb0140) 2012; 42
Kraus, Haack, Schuld, Hinze-Selch, Koethe, Pollmächer (bb0165) 2002; 35
Schmidt, Schröder, Kirkby, Sander, Suslow, Holdt, Teupser, Hegerl, Himmerich (bb0260) 2016; 239
Dowlati, Herrmann, Swardfager, Liu, Sham, Reim, Lanctôt (bb0060) 2010; 2010
Li, Qi, Chen, Zhang, Yi, Yuan, Wang, Hong, Yu, Cui, Fang (bb0175) 2013; 38
Halaris, Myint, Savant, Meresh, Lim, Guillemin, Hoppensteadt, Fareed, Sinacore (bb0110) 2015; 66-67
Maes, Meltzer, Bosmans, Bergmans, Vandoolaeghe, Ranjan, Desnyder (bb0185) 1995; 34
Mackay, Forrest, Christofides, Bridel, Mitchell, Cowlard, Stone, Darlington (bb0180) 2009; 36
Ohgi, Futamura, Kikuchi, Hashimoto (bb0230) 2013; 103
Hernandez, Mendieta, Pérez-Tapia, Bojalil, Estrada-Garcia, Estrada-Parra, Pavón (bb0130) 2013; 2013
Ranjbar, Shams, Sabetkasaei, M-Shirazi, Rashidkhani, Mostafavi, Bornak, Nasrollahzadeh (bb0245) 2014; 17
Gold, Chrousos (bb0100) 2002; 7
Słuzewska, Rybakowski, Laciak, Mackiewicz, Sobieska, Wiktorowicz (bb0270) 1995; 762
Valkanova, Ebmeier, Allan (bb0290) 2013; 150
Gupta, Gupta, Tripathi, Bhatia, Gupta (bb0105) 2016; 97
Zunszain, Anacker, Cattaneo, Choudhury, Musaelyan, Myint, Thuret, Price, Pariante (bb0305) 2012; 37
Jazayeri, Keshavarz, Tehrani-Doost, Djalali, Hosseini, Amini, Chamari, Djazayery (bb0150) 2010; 178
Benton, Lynch, Dube, Gettes, Tustin, Ping Lai, Metzger, Blume, Douglas, Evans (bb0020) 2010; 72
Kocki, Wnuk, Kloc, Kocki, Owe-Larsson, Urbanska (bb0155) 2012; 119
Elenkov (bb0070) 2008; 52
Olajossy, Olajossy, Potembska, Skoczen, Wnuk, Urbańska (bb0235) 2014; 9
DerSimonian, Laird (bb0055) 1986; 7
Rothermundt, Arolt, Fenker, Gutbrodt, Peters, Kirchner (bb0250) 2001; 251
Martino, Rocchi, Escelsior, Fornaro (bb0200) 2012; 10
Hashimoto (bb0120) 2015; 16
Zunszain (10.1016/j.pnpbp.2017.04.026_bb0305) 2012; 37
Li (10.1016/j.pnpbp.2017.04.026_bb0175) 2013; 38
Frommberger (10.1016/j.pnpbp.2017.04.026_bb0095) 1997; 247
Ohgi (10.1016/j.pnpbp.2017.04.026_bb0230) 2013; 103
Benton (10.1016/j.pnpbp.2017.04.026_bb0020) 2010; 72
Crnković (10.1016/j.pnpbp.2017.04.026_bb0040) 2012; 51
Hernandez (10.1016/j.pnpbp.2017.04.026_bb0130) 2013; 2013
Kocki (10.1016/j.pnpbp.2017.04.026_bb0155) 2012; 119
Maes (10.1016/j.pnpbp.2017.04.026_bb0185) 1995; 34
Myint (10.1016/j.pnpbp.2017.04.026_bb0215) 2007; 98
Köhler (10.1016/j.pnpbp.2017.04.026_bb0160) 2014; 71
Brunoni (10.1016/j.pnpbp.2017.04.026_bb0025) 2014; 231
Gold (10.1016/j.pnpbp.2017.04.026_bb0100) 2002; 7
Chang (10.1016/j.pnpbp.2017.04.026_bb0030) 2012; 26
Chen (10.1016/j.pnpbp.2017.04.026_bb0035) 2010; 2010
Słuzewska (10.1016/j.pnpbp.2017.04.026_bb0270) 1995; 762
Hernández (10.1016/j.pnpbp.2017.04.026_bb0125) 2008; 18
Mikova (10.1016/j.pnpbp.2017.04.026_bb0205) 2001; 11
Elenkov (10.1016/j.pnpbp.2017.04.026_bb0070) 2008; 52
Dowlati (10.1016/j.pnpbp.2017.04.026_bb0060) 2010; 2010
Jazayeri (10.1016/j.pnpbp.2017.04.026_bb0150) 2010; 178
Rothermundt (10.1016/j.pnpbp.2017.04.026_bb0250) 2001; 251
Sutcigil (10.1016/j.pnpbp.2017.04.026_bb0280) 2007; 2007
Ninan (10.1016/j.pnpbp.2017.04.026_bb0220) 2014; 48
Drevets (10.1016/j.pnpbp.2017.04.026_bb0065) 2008; 13
Olajossy (10.1016/j.pnpbp.2017.04.026_bb0235) 2014; 9
Hiles (10.1016/j.pnpbp.2017.04.026_bb0140) 2012; 42
Dahl (10.1016/j.pnpbp.2017.04.026_bb0045) 2016; 134
Eller (10.1016/j.pnpbp.2017.04.026_bb0075) 2008; 32
Piletz (10.1016/j.pnpbp.2017.04.026_bb0240) 2009; 10
Abbasi (10.1016/j.pnpbp.2017.04.026_bb0005) 2012; 141
Baumeister (10.1016/j.pnpbp.2017.04.026_bb0015) 2016; 233
Manoharan (10.1016/j.pnpbp.2017.04.026_bb0195) 2016; 31
Yoshimura (10.1016/j.pnpbp.2017.04.026_bb0300) 2013; 28
Fornaro (10.1016/j.pnpbp.2017.04.026_bb0090) 2013; 145
Sacre (10.1016/j.pnpbp.2017.04.026_bb0255) 2010; 62
Halaris (10.1016/j.pnpbp.2017.04.026_bb0110) 2015; 66-67
Lanquillon (10.1016/j.pnpbp.2017.04.026_bb0170) 2000; 22
Tuglu (10.1016/j.pnpbp.2017.04.026_bb0285) 2003; 170
Kraus (10.1016/j.pnpbp.2017.04.026_bb0165) 2002; 35
Hannestad (10.1016/j.pnpbp.2017.04.026_bb0115) 2011; 36
Ranjbar (10.1016/j.pnpbp.2017.04.026_bb0245) 2014; 17
Fornaro (10.1016/j.pnpbp.2017.04.026_bb0085) 2011; 7
Gupta (10.1016/j.pnpbp.2017.04.026_bb0105) 2016; 97
Schmidt (10.1016/j.pnpbp.2017.04.026_bb0260) 2016; 239
Mackay (10.1016/j.pnpbp.2017.04.026_bb0180) 2009; 36
Shelton (10.1016/j.pnpbp.2017.04.026_bb0265) 2011; 2011
Valkanova (10.1016/j.pnpbp.2017.04.026_bb0290) 2013; 150
O'Brien (10.1016/j.pnpbp.2017.04.026_bb0225) 2006; 188
World Health Organization (10.1016/j.pnpbp.2017.04.026_bb0295) 2008
Martino (10.1016/j.pnpbp.2017.04.026_bb0200) 2012; 10
Del Grande da Silva (10.1016/j.pnpbp.2017.04.026_bb0050) 2016; 75
Maes (10.1016/j.pnpbp.2017.04.026_bb0190) 1997; 9
Strawbridge (10.1016/j.pnpbp.2017.04.026_bb0275) 2015; 25
Hinze-Selch (10.1016/j.pnpbp.2017.04.026_bb0145) 2000; 23
DerSimonian (10.1016/j.pnpbp.2017.04.026_bb0055) 1986; 7
Hashimoto (10.1016/j.pnpbp.2017.04.026_bb0120) 2015; 16
Myint (10.1016/j.pnpbp.2017.04.026_bb0210) 2003; 61
Basterzi (10.1016/j.pnpbp.2017.04.026_bb0010) 2005; 20
Higgins (10.1016/j.pnpbp.2017.04.026_bb0135) 2003; 327
References_xml – volume: 48
  start-page: 86
  year: 2014
  end-page: 91
  ident: bb0220
  article-title: BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry
– volume: 9
  start-page: 55
  year: 2014
  end-page: 61
  ident: bb0235
  article-title: The level of kynurenic acid and selected cytokines during antidepresssive treatment
  publication-title: Neuropsychiatria Neuropsychologia
– volume: 2011
  start-page: 751
  year: 2011
  end-page: 762
  ident: bb0265
  article-title: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression
  publication-title: Mol. Psychiatry
– volume: 97
  start-page: 184
  year: 2016
  end-page: 188
  ident: bb0105
  article-title: Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-α in patients of major depressive disorder with severe depression
  publication-title: Pharmacology
– volume: 22
  start-page: 370
  year: 2000
  end-page: 379
  ident: bb0170
  article-title: Cytokine production and treatment response in major depressive disorder
  publication-title: Neuropsychopharmacology
– volume: 150
  start-page: 736
  year: 2013
  end-page: 744
  ident: bb0290
  article-title: CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies
  publication-title: J. Affect. Disord.
– volume: 231
  start-page: 1315
  year: 2014
  end-page: 1323
  ident: bb0025
  article-title: Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
  publication-title: Psychopharmacology
– volume: 98
  start-page: 143
  year: 2007
  end-page: 151
  ident: bb0215
  article-title: Kynurenine pathway in major depression: evidence of impaired neuroprotection
  publication-title: J. Affect. Disord.
– volume: 327
  start-page: 557
  year: 2003
  end-page: 560
  ident: bb0135
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ
– year: 2008
  ident: bb0295
  article-title: The Global Burden of Disease 2004 Update
– volume: 11
  start-page: 203
  year: 2001
  end-page: 208
  ident: bb0205
  article-title: Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis
  publication-title: Eur. Neuropsychopharmacol.
– volume: 20
  start-page: 473
  year: 2005
  end-page: 476
  ident: bb0010
  article-title: IL6 levels decrease with SSRI treatment in patients with major depression
  publication-title: Hum Psychopharmacol.
– volume: 239
  start-page: 85
  year: 2016
  end-page: 91
  ident: bb0260
  article-title: Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression
  publication-title: Psychiatry Res.
– volume: 71
  start-page: 1381
  year: 2014
  end-page: 1391
  ident: bb0160
  article-title: Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials
  publication-title: JAMA Psychiatry
– volume: 9
  start-page: 853
  year: 1997
  end-page: 858
  ident: bb0190
  article-title: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
  publication-title: Cytokine
– volume: 2007
  start-page: 76396
  year: 2007
  ident: bb0280
  article-title: Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy
  publication-title: Clin. Dev. Immunol.
– volume: 18
  start-page: 917
  year: 2008
  end-page: 924
  ident: bb0125
  publication-title: Eur. Neuropsychopharmacol.
– volume: 178
  start-page: 112
  year: 2010
  end-page: 115
  ident: bb0150
  article-title: Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder
  publication-title: Psychiatry Res.
– volume: 7
  start-page: 51
  year: 2011
  end-page: 56
  ident: bb0085
  article-title: Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
  publication-title: Neuropsychiatr. Dis. Treat.
– volume: 52
  start-page: 40
  year: 2008
  end-page: 51
  ident: bb0070
  article-title: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being
  publication-title: Neurochem. Int.
– volume: 61
  start-page: 519
  year: 2003
  end-page: 525
  ident: bb0210
  article-title: Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression
  publication-title: Med. Hypotheses
– volume: 28
  start-page: 466
  year: 2013
  end-page: 470
  ident: bb0300
  article-title: Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
  publication-title: Hum Psychopharmacol.
– volume: 2010
  start-page: 446
  year: 2010
  end-page: 457
  ident: bb0060
  article-title: A meta-analysis of cytokines in major depression
  publication-title: Biol. Psychiatry
– volume: 13
  start-page: 663
  year: 2008
  end-page: 681
  ident: bb0065
  article-title: The subgenual anterior cingulate cortex in mood disorders
  publication-title: CNS Spectr.
– volume: 10
  start-page: 313
  year: 2009
  end-page: 323
  ident: bb0240
  article-title: Pro-inflammatory biomakers in depression: treatment with venlafaxine
  publication-title: World J. Biol. Psychiatry
– volume: 75
  start-page: 57
  year: 2016
  end-page: 64
  ident: bb0050
  article-title: Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial
  publication-title: J. Psychiatr. Res.
– volume: 16
  start-page: 7796
  year: 2015
  end-page: 7801
  ident: bb0120
  article-title: Inflammatory biomarkers as differential predictors of antidepressant response
  publication-title: Int. J. Mol. Sci.
– volume: 170
  start-page: 429
  year: 2003
  end-page: 433
  ident: bb0285
  article-title: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
  publication-title: Psychopharmacology
– volume: 25
  start-page: 1532
  year: 2015
  end-page: 1543
  ident: bb0275
  article-title: Inflammation and clinical response to treatment in depression: a meta-analysis
  publication-title: Eur. Neuropsychopharmacol.
– volume: 7
  start-page: 177
  year: 1986
  end-page: 188
  ident: bb0055
  article-title: Meta-analysis in clinical trials
  publication-title: Control. Clin. Trials
– volume: 103
  start-page: 856
  year: 2013
  end-page: 859
  ident: bb0230
  article-title: Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration
  publication-title: Pharmacol. Biochem. Behav.
– volume: 17
  start-page: 65
  year: 2014
  end-page: 71
  ident: bb0245
  article-title: Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression
  publication-title: Nutr. Neurosci.
– volume: 72
  start-page: 925
  year: 2010
  end-page: 932
  ident: bb0020
  article-title: Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication
  publication-title: Psychosom. Med.
– volume: 134
  start-page: 40
  year: 2016
  end-page: 47
  ident: bb0045
  article-title: Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels
  publication-title: Acta Psychiatr. Scand.
– volume: 42
  start-page: 2015
  year: 2012
  end-page: 2026
  ident: bb0140
  article-title: Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
  publication-title: Psychol. Med.
– volume: 10
  start-page: 97
  year: 2012
  end-page: 123
  ident: bb0200
  article-title: Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance
  publication-title: Curr. Neuropharmacol.
– volume: 251
  start-page: 90
  year: 2001
  end-page: 97
  ident: bb0250
  article-title: Different immune patterns in melancholic and non-melancholic major depression
  publication-title: Eur. Arch. Psychiatry Clin. Neurosci.
– volume: 32
  start-page: 445
  year: 2008
  end-page: 450
  ident: bb0075
  article-title: Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry
– volume: 7
  start-page: 254
  year: 2002
  end-page: 275
  ident: bb0100
  article-title: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
  publication-title: Mol. Psychiatry
– volume: 141
  start-page: 308
  year: 2012
  end-page: 314
  ident: bb0005
  article-title: Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study
  publication-title: J. Affect. Disord.
– volume: 23
  start-page: 13
  year: 2000
  end-page: 19
  ident: bb0145
  article-title: Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine
  publication-title: Neuropsychopharmacology
– volume: 119
  start-page: 235
  year: 2012
  end-page: 243
  ident: bb0155
  article-title: New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio
  publication-title: J. Neural. Transm. (Vienna)
– volume: 2010
  start-page: 573
  year: 2010
  end-page: 594
  ident: bb0035
  article-title: Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males
  publication-title: Mediat. Inflamm.
– volume: 51
  start-page: 25
  year: 2012
  end-page: 33
  ident: bb0040
  article-title: Connection between inflammatory markers, antidepressants and depression
  publication-title: Acta Clin. Croat.
– volume: 34
  start-page: 301
  year: 1995
  end-page: 309
  ident: bb0185
  article-title: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
  publication-title: J. Affect. Disord.
– volume: 188
  start-page: 449
  year: 2006
  end-page: 452
  ident: bb0225
  article-title: 2006. Antidepressant therapy and C-reactive protein levels
  publication-title: Br. J. Psychiatry
– volume: 38
  start-page: 107
  year: 2013
  end-page: 114
  ident: bb0175
  article-title: Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study
  publication-title: Psychoneuroendocrinology
– volume: 762
  start-page: 474
  year: 1995
  end-page: 476
  ident: bb0270
  article-title: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 35
  start-page: 220
  year: 2002
  end-page: 225
  ident: bb0165
  article-title: Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine
  publication-title: Pharmacopsychiatry
– volume: 247
  start-page: 228
  year: 1997
  end-page: 233
  ident: bb0095
  article-title: 1997. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission
  publication-title: Eur. Arch. Psychiatry Clin. Neurosci.
– volume: 36
  start-page: 2452
  year: 2011
  end-page: 2459
  ident: bb0115
  article-title: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis
  publication-title: Neuropsychopharmacology
– volume: 2013
  start-page: 267871
  year: 2013
  ident: bb0130
  article-title: Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder
  publication-title: Clin. Dev. Immunol.
– volume: 145
  start-page: 300
  year: 2013
  end-page: 307
  ident: bb0090
  article-title: Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds
  publication-title: J. Affect. Disord.
– volume: 233
  start-page: 1575
  year: 2016
  end-page: 1589
  ident: bb0015
  article-title: Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?
  publication-title: Psychopharmacology
– volume: 36
  start-page: 425
  year: 2009
  end-page: 435
  ident: bb0180
  article-title: Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling
  publication-title: Clin. Exp. Pharmacol. Physiol.
– volume: 37
  start-page: 939
  year: 2012
  end-page: 949
  ident: bb0305
  article-title: Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis
  publication-title: Neuropsychopharmacology
– volume: 31
  start-page: 178
  year: 2016
  end-page: 184
  ident: bb0195
  article-title: Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine
  publication-title: Hum Psychopharmacol.
– volume: 62
  start-page: 683
  year: 2010
  end-page: 693
  ident: bb0255
  article-title: Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors
  publication-title: Arthritis Rheum.
– volume: 26
  start-page: 90
  year: 2012
  end-page: 95
  ident: bb0030
  article-title: Treatment response and cognitive impairment in major depression: association with C-reactive protein
  publication-title: Brain Behav. Immun.
– volume: 66-67
  start-page: 118
  year: 2015
  end-page: 126
  ident: bb0110
  article-title: Does escitalopram reduce neurotoxicity in major depression?
  publication-title: J. Psychiatr. Res.
– volume: 38
  start-page: 107
  issue: 1
  year: 2013
  ident: 10.1016/j.pnpbp.2017.04.026_bb0175
  article-title: Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2012.05.005
– volume: 13
  start-page: 663
  issue: 8
  year: 2008
  ident: 10.1016/j.pnpbp.2017.04.026_bb0065
  article-title: The subgenual anterior cingulate cortex in mood disorders
  publication-title: CNS Spectr.
  doi: 10.1017/S1092852900013754
– volume: 145
  start-page: 300
  issue: 3
  year: 2013
  ident: 10.1016/j.pnpbp.2017.04.026_bb0090
  article-title: Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2012.08.007
– volume: 25
  start-page: 1532
  issue: 10
  year: 2015
  ident: 10.1016/j.pnpbp.2017.04.026_bb0275
  article-title: Inflammation and clinical response to treatment in depression: a meta-analysis
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2015.06.007
– volume: 17
  start-page: 65
  issue: 2
  year: 2014
  ident: 10.1016/j.pnpbp.2017.04.026_bb0245
  article-title: Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression
  publication-title: Nutr. Neurosci.
  doi: 10.1179/1476830513Y.0000000066
– volume: 2010
  start-page: 446
  issue: 67
  year: 2010
  ident: 10.1016/j.pnpbp.2017.04.026_bb0060
  article-title: A meta-analysis of cytokines in major depression
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2009.09.033
– volume: 97
  start-page: 184
  issue: 3–4
  year: 2016
  ident: 10.1016/j.pnpbp.2017.04.026_bb0105
  article-title: Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-α in patients of major depressive disorder with severe depression
  publication-title: Pharmacology
  doi: 10.1159/000444220
– volume: 36
  start-page: 425
  issue: 4
  year: 2009
  ident: 10.1016/j.pnpbp.2017.04.026_bb0180
  article-title: Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling
  publication-title: Clin. Exp. Pharmacol. Physiol.
  doi: 10.1111/j.1440-1681.2008.05077.x
– volume: 16
  start-page: 7796
  issue: 4
  year: 2015
  ident: 10.1016/j.pnpbp.2017.04.026_bb0120
  article-title: Inflammatory biomarkers as differential predictors of antidepressant response
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms16047796
– volume: 134
  start-page: 40
  issue: 1
  year: 2016
  ident: 10.1016/j.pnpbp.2017.04.026_bb0045
  article-title: Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels
  publication-title: Acta Psychiatr. Scand.
  doi: 10.1111/acps.12576
– volume: 36
  start-page: 2452
  issue: 12
  year: 2011
  ident: 10.1016/j.pnpbp.2017.04.026_bb0115
  article-title: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.132
– volume: 48
  start-page: 86
  year: 2014
  ident: 10.1016/j.pnpbp.2017.04.026_bb0220
  article-title: BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry
  doi: 10.1016/j.pnpbp.2013.09.016
– volume: 9
  start-page: 55
  issue: 2
  year: 2014
  ident: 10.1016/j.pnpbp.2017.04.026_bb0235
  article-title: The level of kynurenic acid and selected cytokines during antidepresssive treatment
  publication-title: Neuropsychiatria Neuropsychologia
– volume: 61
  start-page: 519
  issue: 5–6
  year: 2003
  ident: 10.1016/j.pnpbp.2017.04.026_bb0210
  article-title: Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression
  publication-title: Med. Hypotheses
  doi: 10.1016/S0306-9877(03)00207-X
– volume: 170
  start-page: 429
  issue: 4
  year: 2003
  ident: 10.1016/j.pnpbp.2017.04.026_bb0285
  article-title: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-003-1566-z
– volume: 150
  start-page: 736
  issue: 3
  year: 2013
  ident: 10.1016/j.pnpbp.2017.04.026_bb0290
  article-title: CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2013.06.004
– volume: 7
  start-page: 51
  year: 2011
  ident: 10.1016/j.pnpbp.2017.04.026_bb0085
  article-title: Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
  publication-title: Neuropsychiatr. Dis. Treat.
  doi: 10.2147/NDT.S16382
– volume: 22
  start-page: 370
  issue: 4
  year: 2000
  ident: 10.1016/j.pnpbp.2017.04.026_bb0170
  article-title: Cytokine production and treatment response in major depressive disorder
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(99)00134-7
– volume: 71
  start-page: 1381
  issue: 12
  year: 2014
  ident: 10.1016/j.pnpbp.2017.04.026_bb0160
  article-title: Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2014.1611
– volume: 247
  start-page: 228
  issue: 4
  year: 1997
  ident: 10.1016/j.pnpbp.2017.04.026_bb0095
  article-title: 1997. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission
  publication-title: Eur. Arch. Psychiatry Clin. Neurosci.
  doi: 10.1007/BF02900219
– volume: 233
  start-page: 1575
  issue: 9
  year: 2016
  ident: 10.1016/j.pnpbp.2017.04.026_bb0015
  article-title: Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-015-4044-5
– volume: 7
  start-page: 177
  year: 1986
  ident: 10.1016/j.pnpbp.2017.04.026_bb0055
  article-title: Meta-analysis in clinical trials
  publication-title: Control. Clin. Trials
  doi: 10.1016/0197-2456(86)90046-2
– volume: 119
  start-page: 235
  issue: 2
  year: 2012
  ident: 10.1016/j.pnpbp.2017.04.026_bb0155
  article-title: New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio
  publication-title: J. Neural. Transm. (Vienna)
  doi: 10.1007/s00702-011-0668-8
– volume: 75
  start-page: 57
  year: 2016
  ident: 10.1016/j.pnpbp.2017.04.026_bb0050
  article-title: Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2016.01.008
– volume: 52
  start-page: 40
  issue: 1-2
  year: 2008
  ident: 10.1016/j.pnpbp.2017.04.026_bb0070
  article-title: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2007.06.037
– volume: 141
  start-page: 308
  issue: 2–3
  year: 2012
  ident: 10.1016/j.pnpbp.2017.04.026_bb0005
  article-title: Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2012.03.033
– volume: 23
  start-page: 13
  issue: 1
  year: 2000
  ident: 10.1016/j.pnpbp.2017.04.026_bb0145
  article-title: Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00089-0
– volume: 10
  start-page: 97
  issue: 2
  year: 2012
  ident: 10.1016/j.pnpbp.2017.04.026_bb0200
  article-title: Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance
  publication-title: Curr. Neuropharmacol.
  doi: 10.2174/157015912800604542
– volume: 10
  start-page: 313
  issue: 4
  year: 2009
  ident: 10.1016/j.pnpbp.2017.04.026_bb0240
  article-title: Pro-inflammatory biomakers in depression: treatment with venlafaxine
  publication-title: World J. Biol. Psychiatry
  doi: 10.3109/15622970802573246
– volume: 239
  start-page: 85
  year: 2016
  ident: 10.1016/j.pnpbp.2017.04.026_bb0260
  article-title: Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression
  publication-title: Psychiatry Res.
  doi: 10.1016/j.psychres.2016.02.052
– volume: 98
  start-page: 143
  issue: 1–2
  year: 2007
  ident: 10.1016/j.pnpbp.2017.04.026_bb0215
  article-title: Kynurenine pathway in major depression: evidence of impaired neuroprotection
  publication-title: J. Affect. Disord.
  doi: 10.1016/j.jad.2006.07.013
– volume: 7
  start-page: 254
  issue: 3
  year: 2002
  ident: 10.1016/j.pnpbp.2017.04.026_bb0100
  article-title: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
  publication-title: Mol. Psychiatry
  doi: 10.1038/sj.mp.4001032
– volume: 231
  start-page: 1315
  issue: 7
  year: 2014
  ident: 10.1016/j.pnpbp.2017.04.026_bb0025
  article-title: Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-013-3322-3
– volume: 72
  start-page: 925
  issue: 9
  year: 2010
  ident: 10.1016/j.pnpbp.2017.04.026_bb0020
  article-title: Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication
  publication-title: Psychosom. Med.
  doi: 10.1097/PSY.0b013e3181f883ce
– volume: 18
  start-page: 917
  issue: 12
  year: 2008
  ident: 10.1016/j.pnpbp.2017.04.026_bb0125
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2008.08.001
– volume: 35
  start-page: 220
  issue: 6
  year: 2002
  ident: 10.1016/j.pnpbp.2017.04.026_bb0165
  article-title: Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine
  publication-title: Pharmacopsychiatry
  doi: 10.1055/s-2002-36390
– volume: 178
  start-page: 112
  issue: 1
  year: 2010
  ident: 10.1016/j.pnpbp.2017.04.026_bb0150
  article-title: Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder
  publication-title: Psychiatry Res.
  doi: 10.1016/j.psychres.2009.04.013
– volume: 188
  start-page: 449
  year: 2006
  ident: 10.1016/j.pnpbp.2017.04.026_bb0225
  article-title: 2006. Antidepressant therapy and C-reactive protein levels
  publication-title: Br. J. Psychiatry
  doi: 10.1192/bjp.bp.105.011015
– volume: 9
  start-page: 853
  issue: 11
  year: 1997
  ident: 10.1016/j.pnpbp.2017.04.026_bb0190
  article-title: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
  publication-title: Cytokine
  doi: 10.1006/cyto.1997.0238
– volume: 28
  start-page: 466
  issue: 5
  year: 2013
  ident: 10.1016/j.pnpbp.2017.04.026_bb0300
  article-title: Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
  publication-title: Hum Psychopharmacol.
  doi: 10.1002/hup.2333
– volume: 251
  start-page: 90
  year: 2001
  ident: 10.1016/j.pnpbp.2017.04.026_bb0250
  article-title: Different immune patterns in melancholic and non-melancholic major depression
  publication-title: Eur. Arch. Psychiatry Clin. Neurosci.
  doi: 10.1007/s004060170058
– volume: 2013
  start-page: 267871
  year: 2013
  ident: 10.1016/j.pnpbp.2017.04.026_bb0130
  article-title: Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder
  publication-title: Clin. Dev. Immunol.
  doi: 10.1155/2013/267871
– volume: 62
  start-page: 683
  issue: 3
  year: 2010
  ident: 10.1016/j.pnpbp.2017.04.026_bb0255
  article-title: Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.27304
– volume: 34
  start-page: 301
  issue: 4
  year: 1995
  ident: 10.1016/j.pnpbp.2017.04.026_bb0185
  article-title: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
  publication-title: J. Affect. Disord.
  doi: 10.1016/0165-0327(95)00028-L
– volume: 66-67
  start-page: 118
  year: 2015
  ident: 10.1016/j.pnpbp.2017.04.026_bb0110
  article-title: Does escitalopram reduce neurotoxicity in major depression?
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2015.04.026
– volume: 37
  start-page: 939
  issue: 4
  year: 2012
  ident: 10.1016/j.pnpbp.2017.04.026_bb0305
  article-title: Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.277
– volume: 2010
  start-page: 573
  year: 2010
  ident: 10.1016/j.pnpbp.2017.04.026_bb0035
  article-title: Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males
  publication-title: Mediat. Inflamm.
  doi: 10.1155/2010/573594
– volume: 20
  start-page: 473
  issue: 7
  year: 2005
  ident: 10.1016/j.pnpbp.2017.04.026_bb0010
  article-title: IL6 levels decrease with SSRI treatment in patients with major depression
  publication-title: Hum Psychopharmacol.
  doi: 10.1002/hup.717
– volume: 2007
  start-page: 76396
  year: 2007
  ident: 10.1016/j.pnpbp.2017.04.026_bb0280
  article-title: Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy
  publication-title: Clin. Dev. Immunol.
  doi: 10.1155/2007/76396
– volume: 42
  start-page: 2015
  issue: 10
  year: 2012
  ident: 10.1016/j.pnpbp.2017.04.026_bb0140
  article-title: Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
  publication-title: Psychol. Med.
  doi: 10.1017/S0033291712000128
– volume: 32
  start-page: 445
  issue: 2
  year: 2008
  ident: 10.1016/j.pnpbp.2017.04.026_bb0075
  article-title: Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry
  doi: 10.1016/j.pnpbp.2007.09.015
– year: 2008
  ident: 10.1016/j.pnpbp.2017.04.026_bb0295
– volume: 26
  start-page: 90
  issue: 1
  year: 2012
  ident: 10.1016/j.pnpbp.2017.04.026_bb0030
  article-title: Treatment response and cognitive impairment in major depression: association with C-reactive protein
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2011.07.239
– volume: 2011
  start-page: 751
  issue: 16
  year: 2011
  ident: 10.1016/j.pnpbp.2017.04.026_bb0265
  article-title: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression
  publication-title: Mol. Psychiatry
  doi: 10.1038/mp.2010.52
– volume: 327
  start-page: 557
  year: 2003
  ident: 10.1016/j.pnpbp.2017.04.026_bb0135
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ
  doi: 10.1136/bmj.327.7414.557
– volume: 31
  start-page: 178
  issue: 3
  year: 2016
  ident: 10.1016/j.pnpbp.2017.04.026_bb0195
  article-title: Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine
  publication-title: Hum Psychopharmacol.
  doi: 10.1002/hup.2525
– volume: 51
  start-page: 25
  issue: 1
  year: 2012
  ident: 10.1016/j.pnpbp.2017.04.026_bb0040
  article-title: Connection between inflammatory markers, antidepressants and depression
  publication-title: Acta Clin. Croat.
– volume: 11
  start-page: 203
  issue: 3
  year: 2001
  ident: 10.1016/j.pnpbp.2017.04.026_bb0205
  article-title: Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/S0924-977X(01)00081-5
– volume: 103
  start-page: 856
  year: 2013
  ident: 10.1016/j.pnpbp.2017.04.026_bb0230
  article-title: Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration
  publication-title: Pharmacol. Biochem. Behav.
  doi: 10.1016/j.pbb.2012.12.003
– volume: 762
  start-page: 474
  year: 1995
  ident: 10.1016/j.pnpbp.2017.04.026_bb0270
  article-title: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.1995.tb32372.x
SSID ssj0001303
Score 2.5809426
SecondaryResourceType review_article
Snippet Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 217
SubjectTerms Antidepressants
Antidepressive Agents - pharmacology
Antidepressive Agents - therapeutic use
Biomarkers - blood
Cytokines
Cytokines - blood
Depression
Depressive Disorder, Major - blood
Depressive Disorder, Major - drug therapy
Depressive Disorder, Major - immunology
Female
Humans
Inflammation
Inflammation Mediators - blood
Male
Meta-analysis
Title Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
URI https://dx.doi.org/10.1016/j.pnpbp.2017.04.026
https://www.ncbi.nlm.nih.gov/pubmed/28445690
https://www.proquest.com/docview/1892725594
Volume 80
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LS8QwEICD6MWL-HZ9EUE8bd0-0kl6XERZFUVQQU-heRRWtLu468GL-B_8h_4SM2m7i6AevLWloSUzmZkkM18I2VcqMy5S0IGJCxMwG2WBEGADmzGmwc2DlMc1XVxC75ad3aV3M-SoqYXBtMra9lc23Vvr-kmn7s3OsN_vXOOeGbrPCJHrkGIRH2MctfzwbZrmgTbar7NwrDBi0JCHfI7XsBwqhFZG3PNOkbDws3f6Lfr0XuhkkSzU4SPtVn-4RGZsuUwOrir-9Gub3kzLqUZtekCvpmTq1xVyX7GK6aCgrkP7dRasu6STfHM6KCnCjz1t4JE6_XMqU5U30idM5Xke0c_3D9qlT3acB3nNNFkltyfHN0e9oD5bIdBulI6dLBItLCRQFML4aV3OdB7G1lgbGx4aRJ8VACYPUx2lWgmVMhUWcQEqzWySrJHZclDaDUJ5AoIJy0GDYpkGEUW54QoUD7MYjGqRuOlTqWvwOJ5_8SibDLMH6QUhURAyZNIJokXak0bDirvx9-vQCEt-Ux_pPMPfDfca0Uo3sHC3JC_t4GUkI5HFHCdcrEXWK5lP_sT5dBd4ZuHmfz-7RebdnfBrOck2mR0_v9gdF92M1a5X310y1z09711-AWVi-1o
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3NTtwwEIBHdDnQSwVtoQuUulLFaaPNjzOxjytUtBRYIXWR4GTFP5EWQXbFLgduvANvyJNgO84ipMKhtyiJlcgznhnbM58BfknJtY0UVKTTSkfUJDxiDE1kOKUK7TxIelzT6QiH5_TPRX6xAgdtLYxLqwy2v7Hp3lqHO_3Qm_3ZZNL_6_bMnPtMHHIdc_4BVh2dKu_A6uDoeDhaGmRnpv1SS-GKjCi28CGf5jWrZ9JxK5PCI08dZOHfDuqtANQ7osN1-BQiSDJofnIDVkz9GfbPGgT1fY-MXyqq5j2yT85e4NT3X-CywRWTaUVsn05CIqy9JMuUczKtieMfe-DANbEqaLWmqXAkNy6b53ZOnh4eyYDcmEUZlQFr8hXOD3-PD4ZROF4hUnagLqw4MsUMZlhVTPuZXUlVGadGG5PqItaOflYh6jLOVZIryWROZVylFcqcmyzbhE49rc03IEWGjDJToEJJuUKWJKUuJMoi5ilq2YW07VOhAnvcHYFxLdoksyvhBSGcIERMhRVEF3rLRrMGvfH-69gKS7zSIGGdw_sNf7aiFXZsuQ2TsjbTu7lIGE8LN-eiXdhqZL78E-vWbezJ4-3__ewPWBuOT0_EydHoeAc-2ifML-1ku9BZ3N6Z7zbYWci9oMzP-z3-Cw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+antidepressant+treatment+on+peripheral+inflammation+markers+%E2%80%93+A+meta-analysis&rft.jtitle=Progress+in+neuro-psychopharmacology+%26+biological+psychiatry&rft.au=Wi%C4%99d%C5%82ocha%2C+Magdalena&rft.au=Marcinowicz%2C+Piotr&rft.au=Krupa%2C+Renata&rft.au=Janoska-Ja%C5%BAdzik%2C+Marlena&rft.date=2018-01-03&rft.issn=0278-5846&rft.volume=80&rft.spage=217&rft.epage=226&rft_id=info:doi/10.1016%2Fj.pnpbp.2017.04.026&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_pnpbp_2017_04_026
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-5846&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-5846&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-5846&client=summon